{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-182591","form_type":"8-K","ticker":"HCA","cik":"0000860730","company_name":"HCA Healthcare, Inc.","filed_at":"2024-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.062566+00:00","generated_at":"2026-05-31T18:21:56.782695+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"HCA Q2 2024 rev $17.49B, EPS $5.53, raises FY guidance","bullets":["Revenue $17.492B (+10.3% YoY); net income $1.461B ($5.53 diluted EPS) vs $1.193B ($4.29).","Adjusted EBITDA $3.550B (+16.2% YoY); same facility admissions +5.8%, ER visits +5.5%.","FY2024 guidance raised: rev $69.75-71.75B (prev $67.75-70.25B), EPS $21.60-22.80 (prev $19.70-21.20).","Board declared quarterly dividend $0.66/share, payable Sept 30, record Sept 16.","Repurchased 4.217M shares at $1.367B in Q2; $4.228B remaining under buyback authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-182591","json":"https://secwatch.observer/filing/0001193125-24-182591.json","markdown":"https://secwatch.observer/filing/0001193125-24-182591.md","text":"https://secwatch.observer/filing/0001193125-24-182591.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/860730/000119312524182591/0001193125-24-182591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/860730/000119312524182591/d873924d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T18:21:56.782695+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}